281
Participants
Start Date
December 31, 2006
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Zemplar (paricalcitol ) capsules
Group 2 - paricalcitol 1 mcg capsules once daily (one paricalcitol 1 mcg capsule once daily and one matching placebo capsule once daily)
Zemplar (paricalcitol) capsules
Group 3 - paricalcitol 2 mcg capsules once daily (two paricalcitol 1 mcg capsules once daily)
Placebo
Group 1 - Placebo once daily (two placebo capsules once daily)
Site Reference ID/Investigator# 7927, Taichung
Site Reference ID/Investigator# 6294, Taipei
Site Reference ID/Investigator# 8046, Albany
Site Reference ID/Investigator# 7495, Carlisle
Site Reference ID/Investigator# 6314, Athens
Site Reference ID/Investigator# 6309, Milan
Site Reference ID/Investigator# 854, Rockville
Site Reference ID/Investigator# 6312, Bergamo
Site Reference ID/Investigator# 6303, Brescia
Site Reference ID/Investigator# 6626, Winston-Salem
Site Reference ID/Investigator# 8039, Greenville
Site Reference ID/Investigator# 5111, Madrid
Site Reference ID/Investigator# 866, Charlotte
Site Reference ID/Investigator# 8053, Morehead City
Site Reference ID/Investigator# 7113, Roswell
Site Reference ID/Investigator# 5167, Hanover
Site Reference ID/Investigator# 5110, Oviedo
Site Reference ID/Investigator# 857, Pembroke Pines
Site Reference ID/Investigator# 867, Lauderdale Lakes
Site Reference ID/Investigator# 8901, West Palm Beach
Site Reference ID/Investigator# 853, Hudson
Site Reference ID/Investigator# 6329, Santander
Site Reference ID/Investigator# 5622, Katowice
Site Reference ID/Investigator# 6316, Düsseldorf
Site Reference ID/Investigator# 8335, Taichung
Site Reference ID/Investigator# 6210, Modena
Site Reference ID/Investigator# 6306, Ioannina
Site Reference ID/Investigator# 11281, Valencia
Site Reference ID/Investigator# 869, Indianapolis
Site Reference ID/Investigator# 10621, Galdakao
Site Reference ID/Investigator# 5631, Thessaloniki
Site Reference ID/Investigator# 6310, Thessaloniki
Site Reference ID/Investigator# 859, Brooklyn Center
Site Reference ID/Investigator# 3371, Evanston
Site Reference ID/Investigator# 2531, Chicago
Site Reference ID/Investigator# 6302, Ludwigshafen
Site Reference ID/Investigator# 7214, Omaha
Site Reference ID/Investigator# 8054, Baton Rouge
Site Reference ID/Investigator# 9061, Dallas
Site Reference ID/Investigator# 8325, Dallas
Site Reference ID/Investigator# 856, Dallas
Site Reference ID/Investigator# 7494, San Antonio
Site Reference ID/Investigator# 774, San Antonio
Site Reference ID/Investigator# 862, Phoenix
Site Reference ID/Investigator# 864, Fountain Valley
Site Reference ID/Investigator# 7291, Yuba City
Site Reference ID/Investigator# 6281, Boston
Site Reference ID/Investigator# 6207, Groningen
Site Reference ID/Investigator# 6304, Bydgoszcz
Site Reference ID/Investigator# 5203, Szczecin
Site Reference ID/Investigator# 6315, Warsaw
Site Reference ID/Investigator# 5170, San Juan
Site Reference ID/Investigator# 6327, Lisbon
Site Reference ID/Investigator# 6326, Porto
Site Reference ID/Investigator# 6916, Caguas
Site Reference ID/Investigator# 5175, Carolina
Site Reference ID/Investigator# 6290, Las Piedras
Site Reference ID/Investigator# 5179, Ponce
Site Reference ID/Investigator# 6293, Ponce
Site Reference ID/Investigator# 5173, Ponce
Site Reference ID/Investigator# 6300, Ponce
Site Reference ID/Investigator# 5168, Ponce
Site Reference ID/Investigator# 7298, Rio Piedras
Site Reference ID/Investigator# 7509, San Juan
Site Reference ID/Investigator# 6288, San Juan
Site Reference ID/Investigator# 6291, San Juan
Site Reference ID/Investigator# 6919, Toa Baja
Site Reference ID/Investigator# 6296, Yabucoa
Site Reference ID/Investigator# 6569, Barcelona
Site Reference ID/Investigator# 6330, L'Hospitalet de
Site Reference ID/Investigator# 6285, Taipei
Site Reference ID/Investigator# 6286, Xinzhuang
Lead Sponsor
Abbott
INDUSTRY